MIT researchers combine deep learning and physics to fix motion-corrupted MRI scans
The challenge involves more than just a blurry JPEG. Fixing motion artifacts in medical imaging requires a more sophisticated approach.
The challenge involves more than just a blurry JPEG. Fixing motion artifacts in medical imaging requires a more sophisticated approach.
MIT researchers investigate the causes of health care disparities among underrepresented groups.
Three graduate students forged a path to the same Picower Institute lab through participating in the MIT Summer Research Program in Biology and Neuroscience.
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
Evaluating articles and journals using a new “diversity index” could promote a wider range of perspectives and better global health outcomes, researchers say.
Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors.
MIT PhD student Kathrin Kajderowicz is studying how hibernation-like states could pave the way for new hypothermic therapies.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
Biologist Nicole De Nisco ’07, PhD ’13 draws on her love of problem-solving and interdisciplinary skills honed as a student at MIT.
The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.
In her latest book, “We’ve Got You Covered,” Amy Finkelstein prescribes a complete overhaul of our health insurance system.
A pilot-scale system, enabled by an $82 million award from the FDA, aims to accelerate the development and production of mRNA technologies.
“FrameDiff” is a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.